Vertical: CNMBase Year: 2025
Market Size (2025)
$185.01M
Projected (2032)
$252.40M
CAGR (2022–2032)
4.5%
Key Players
11+
Market Overview
The Global Aquaculture Water Treatment Chemicals Market was valued at USD 185.01 Million in 2025 and is projected to reach USD 252.40 Million by 2032, registering a CAGR of 4.54% over the forecast period 2026–2032. The market expanded from USD 161.90 Million in 2022 to USD 176.97 Million in 2024, and is expected to add USD 67.39 Million in absolute terms between 2025 and 2032.
Aquaculture water treatment chemicals are applied directly to culture water and pond sediments to keep pH, alkalinity, dissolved oxygen, ammonia, nitrite, hydrogen sulphide and microbial load within ranges that support the survival and growth of farmed shrimp, fish and other aquatic species. Demand is tied closely to the expansion and intensification of pond, tank and recirculating aquaculture systems, to recurrent disease pressure in shrimp farming, and to regulatory restrictions on antibiotic use that have shifted farmers towards preventive water and soil management. Asia Pacific, which hosts the bulk of global aquaculture output, accounts for the dominant share of consumption.
Key Findings
Product type: The largest segments in 2025 are pH Adjusters & Buffers and Oxygen Releasers & Others, each valued at USD 64.75 Million in 2025 (35.00% share each). Probiotics is the fastest-growing product type, at a CAGR of 5.50% over 2026–2032.
Species: The largest segment is Shrimp, valued at USD 92.51 Million in 2025 (50.00% share). The fastest-growing segment is Others, at a CAGR of 4.91% (marginally ahead of Shrimp, which also rounds to 4.91%).
Region: Asia Pacific leads the market with USD 148.01 Million in 2025 (80.00% share). Middle East & Africa is the fastest-growing region, at a CAGR of 5.96%.
Country: China is the leading country, with USD 65.12 Million in 2025, equal to 35.20% of the global market. UAE is the fastest-growing country, at a CAGR of 6.55%, followed by Saudi Arabia at 6.50%.
Segmentation Summary
By product type, the market is divided into pH Adjusters & Buffers, Probiotics, and Oxygen Releasers & Others. pH Adjusters & Buffers and Oxygen Releasers & Others each held 35.00% of the market in 2025, reflecting the routine, high-volume use of liming materials, carbonate buffers, mineral blends and oxygen-releasing compounds in pond preparation and day-to-day water management. Probiotics accounted for 30.00% (USD 55.50 Million) but are forecast to grow fastest, at 5.50%, as farmers replace antibiotics and chemical disinfectants with microbial bioremediation. By 2032, Oxygen Releasers & Others is projected to be the largest product type at USD 87.01 Million.
By species, Shrimp is the largest application with USD 92.51 Million in 2025 (50.00%), followed by Fish at USD 74.00 Million (40.00%) and Others at USD 18.50 Million (10.00%). Shrimp ponds are intensively managed and highly sensitive to pH swings, oxygen depletion and toxic gas build-up, which makes them the heaviest per-hectare users of water treatment inputs. Others (4.91%) and Shrimp (4.91%) post near-identical growth rates, while Fish is projected to grow at 3.96%.
Competitive Landscape Summary
The market is fragmented. Global biosolutions and chemical companies, including Novonesis, dsm-firmenich, Evonik Industries and Solvay, supply microbial products and active-oxygen chemistries across multiple regions, while aquaculture-focused specialists such as Benchmark Holdings (INVE Aquaculture), Lallemand Animal Nutrition, Virbac and Kemin Industries compete with broad health and water-quality portfolios. A large number of regional formulators, such as Biostadt India, Growel Formulations and Syndel, serve farmers through dealer networks with probiotics, mineral mixes, oxygen tablets and disinfectants. Corporate activity since 2022 has been dominated by portfolio restructuring, including the formation of Novonesis, the planned divestment of dsm-firmenich's Animal Nutrition & Health business, and the sale of Benchmark's Genetics business.
Challenges and Opportunities
Key challenges include farm-gate price pressure in shrimp and other species, which limits input spending by small and medium farmers; inconsistent product quality and limited efficacy data for many formulated products sold through dealer channels; and increasing environmental and residue scrutiny of chemical treatments. Opportunities lie in multi-strain and application-specific probiotics, in the expansion of aquaculture in Latin America and the Middle East & Africa, and in recirculating and land-based systems, where precise control of pH, alkalinity and oxygen is a core operating requirement.
Future Outlook
The market is expected to grow steadily, from USD 193.42 Million in 2026 to USD 252.40 Million in 2032. Growth will be broad-based across product types, with Probiotics gaining share from 30.00% in 2025 to 32.11% in 2032. Asia Pacific will remain the core of the market, adding USD 54.31 Million between 2025 and 2032, while Latin America (5.39%) and Middle East & Africa (5.96%) are expected to outpace the global average.
The Aquaculture Water Treatment Chemicals Market market is projected to grow at a CAGR of 4.5% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Aquaculture water treatment chemicals are chemical and biological inputs applied to culture water, pond bottoms and tank systems to establish and maintain water quality conditions suitable for farmed aquatic animals. Their functions include correcting and stabilising pH and total alkalinity, supplying dissolved oxygen, reducing ammonia, nitrite and hydrogen sulphide, degrading accumulated organic matter and sludge, and suppressing pathogenic microbial loads.
For the purpose of this study, the market includes the following product types: pH Adjusters & Buffers: agricultural lime (calcium carbonate), quicklime and hydrated lime, dolomite, sodium bicarbonate and other carbonate buffers, and mineral blends used to raise or stabilise pH, alkalinity and hardness.
Probiotics: water- and soil-applied microbial products, including Bacillus-based blends, nitrifying bacteria, photosynthetic bacteria, and enzyme–microbe combinations used for bioremediation and competitive exclusion of pathogens.
Oxygen Releasers & Others: oxygen-releasing compounds such as calcium peroxide, sodium percarbonate and hydrogen peroxide, together with other water treatment inputs such as disinfectants and sanitisers, zeolites and other adsorbents, ammonia and gas binders, and water conditioners.
The study excludes aquaculture feeds and in-feed additives, vaccines and therapeutic veterinary medicines administered orally or by injection, antibiotics, and water treatment equipment such as aerators, filters and recirculation hardware.
Scope of the Study
The study covers the Global Aquaculture Water Treatment Chemicals Market across two segmentations and five regions:
By Product Type: pH Adjusters & Buffers; Probiotics; Oxygen Releasers & Others.
By Species: Shrimp; Fish; Others.
By Region: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, with country-level analysis for 20 countries and country groups.
Timeline: historic years 2022–2024, base year 2025, forecast period 2026–2032; CAGR is presented for 2026–2032.
Unit: market values are presented in USD Million.
Research Objectives
To estimate the size of the Global Aquaculture Water Treatment Chemicals Market for 2022–2025 and forecast it for 2026–2032 in USD Million.
To analyse the market by product type (pH Adjusters & Buffers, Probiotics, and Oxygen Releasers & Others) and identify the segments with the largest share and fastest growth.
To assess demand by species, distinguishing between shrimp, fish and other farmed aquatic species.
To evaluate the market across five regions and their constituent countries and identify high-growth geographies.
To examine the drivers, restraints, opportunities, trends and challenges shaping the use of water treatment inputs in aquaculture, including the shift from antibiotics to biological water management.
To review the regulatory frameworks governing the registration and use of aquaculture water treatment products in major producing and importing regions.
To profile the competitive environment, including positioning of leading suppliers and key developments since 2022.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured process combining secondary research, primary research, market size estimation and forecasting. The process began with defining the market scope and segmentation, followed by collection of production, trade and pricing data for aquaculture and for the principal water treatment inputs. Market estimates were built using both top-down and bottom-up approaches, triangulated, and validated through discussions with industry participants. The final dataset was reviewed for internal consistency across segments, regions and countries.
Secondary Research
Secondary research drew on sources specific to aquaculture and aquaculture inputs, including:
Government and intergovernmental bodies: national fisheries ministries and agencies (such as NOAA Fisheries, the Department of Fisheries of India, Fisheries and Oceans Canada and the Norwegian Directorate of Fisheries), the FAO's fisheries and aquaculture statistics, and regulatory authorities responsible for veterinary medicines, pesticides and biocides.
Regulatory and approval databases: lists of approved aquaculture drugs and low regulatory priority substances, registered antibiotic-free inputs, and authorised feed and water additives.
Industry associations: national and regional aquaculture and seafood associations, shrimp farmer federations, and salmon producer organisations.
Company filings: annual reports, investor presentations and press releases of chemical, biosolutions and animal health companies active in aquaculture.
Trade journals and technical literature: aquaculture trade publications, peer-reviewed studies on pond water quality management and probiotic efficacy, and conference proceedings.
Paid and proprietary databases: trade statistics, company databases and internal market models.
Primary Research
Primary research was conducted through structured and semi-structured interviews with participants across the value chain. Supply-side respondents included product managers, technical service specialists and sales managers at manufacturers and formulators of probiotics, liming materials, mineral blends and active-oxygen products, as well as distributors and aqua-input dealers. Demand-side respondents included shrimp and fish farm owners and managers, hatchery operators, recirculating aquaculture system operators, aquaculture consultants and technical staff at feed and integrated seafood companies.
The objectives of primary research were to validate market size and segment splits, understand application rates and purchasing behaviour by species and region, assess pricing trends, identify emerging products and technologies, and gather qualitative insights on drivers, restraints and competitive dynamics.
Market Size Estimation
Top-down approach: The overall market was derived from total aquaculture production and farmed area by region and species, adjusted for the share of production systems that use water treatment inputs and the typical spend on these inputs per unit of production. Regional totals were then allocated to product types and species using usage patterns identified in the research.
Bottom-up approach: Revenues of key suppliers from relevant aquaculture water treatment products were estimated and aggregated, supplemented by estimates for regional formulators and unbranded commodity supply. Country-level consumption was built from farmed area, stocking intensity, application rates and average product prices.
Data triangulation: The results of the two approaches were compared and reconciled. Differences were resolved by weighting the more reliable inputs for each region and segment and by cross-checking with primary interview findings, to arrive at the final market estimates.
Forecasting Methodology
Forecasts for 2026–2032 were developed by projecting the base-year market using factors that influence demand for aquaculture water treatment inputs. Factors considered include aquaculture production growth by species and region, the pace of intensification and adoption of recirculating systems, disease prevalence in shrimp and fish farming, regulatory restrictions on antibiotics and chemical residues, farm-gate price trends and farmer profitability, government support programmes, product price trends, and the substitution of chemical inputs by biological products. Each factor was assessed for its direction and magnitude of impact over the short, medium and long term, and the resulting growth rates were applied at the segment, region and country level.
Base Year, Forecast Period and Currency
Assumptions and Limitations
Market values are presented at manufacturer and supplier level in nominal USD; currency fluctuations relative to the base year are not modelled separately.
Aquaculture production is assumed to grow without major disruption from pandemics, large-scale trade embargoes or catastrophic disease events beyond historic norms.
Regulatory frameworks are assumed to continue their current direction, with progressive restrictions on antibiotic use and residues.
A substantial share of the market, particularly in Asia, consists of locally formulated and unbranded products, for which data are less complete; estimates for these products rely more heavily on application rates and primary research.
Country groups such as Rest of Europe, Rest of Asia Pacific, Rest of Latin America and Rest of MEA are analysed in aggregate.
Company revenues reported in the competitive landscape are taken from the latest public disclosures and are not adjusted to the market definition used in this study.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The Global Aquaculture Water Treatment Chemicals Market is fragmented. A small number of global chemical and biosolutions companies supply active-oxygen chemicals, carbonate buffers and probiotic strains across multiple regions, while aquaculture-focused animal health and nutrition companies offer broad portfolios of probiotics, water conditioners, oxygen tablets and disinfectants. A large share of demand, especially in Asia, is served by regional and local formulators that buy commodity minerals, peroxides and microbial concentrates and sell finished products through dealer networks close to farming clusters.
Competition is based on product efficacy, field evidence, price, regulatory registration, technical service and distribution reach. In commodity products such as liming materials and mineral blends, price and local availability are decisive. In probiotics and specialty products, suppliers differentiate through proprietary strains, formulation technology, documented field trials and on-farm technical support. Regulatory approvals are an important competitive factor in North America and Europe, where the range of permitted products is narrower. Since 2022, the competitive environment has been reshaped by mergers, divestments and portfolio refocusing among major suppliers.
Key Player Positioning
Based on product portfolio breadth, geographic reach, technological capability and relevance to aquaculture water treatment, the profiled companies are positioned as follows:
Leaders: Novonesis, dsm-firmenich, Evonik Industries and Solvay. These companies combine large-scale production capabilities in microbial strains or active-oxygen chemicals with global distribution, regulatory expertise and research and development resources. Their aquaculture activities are part of larger biosolutions, animal nutrition or chemicals businesses.
Challengers: Benchmark Holdings (INVE Aquaculture), Lallemand Animal Nutrition, Virbac and Kemin Industries. These companies have dedicated aquaculture businesses with strong product portfolios and technical service in key producing regions, particularly in Asia and Latin America, and compete through specialised probiotic, health and water quality ranges.
Niche and regional players: Biostadt India, Growel Formulations and Syndel. These companies hold strong positions in specific countries or product categories, such as pond management products for Indian shrimp farmers or approved water treatment and biosecurity products in North America.
Competitor Dashboard
The competitor dashboard rates each profiled company on four parameters: breadth and relevance of the product portfolio for aquaculture water treatment, regional presence, strategic alliances and industry experience.
Threat of New Entrants: Medium
Barriers to entry are low for formulated mineral blends and basic probiotic products in many Asian markets, where local formulators can enter with limited capital.
Product registration requirements, such as Coastal Aquaculture Authority registration in India and FDA, EPA or veterinary medicine approvals in developed markets, raise entry costs for regulated products.
Scale economies in active-oxygen chemicals and fermentation favour established producers.
Bargaining Power of Suppliers: Medium
Commodity inputs such as limestone, dolomite and soda ash are widely available from many suppliers.
Hydrogen peroxide production is concentrated among a limited number of large chemical producers, which gives them some pricing power.
Proprietary probiotic strains and fermentation capacity are held by a few biosolutions companies, increasing their leverage over formulators.
Bargaining Power of Buyers: High
Most farmers are price-sensitive and can switch between brands easily, with low switching costs.
Large integrators and farm groups buy in volume and negotiate prices directly with manufacturers.
Dealers and distributors influence brand choice at the farm level and demand attractive margins.
Threat of Substitutes: Medium
Mechanical aeration, water exchange and pond drying can partly replace oxygen releasers and some chemical treatments.
Biofloc systems and RAS biofilters reduce reliance on some chemical inputs, although they increase use of buffers and carbon sources.
Within the market, probiotics are substituting for chemical disinfectants in a growing number of applications.
Intensity of Competitive Rivalry: High
The market is fragmented, with global companies competing against many regional and local formulators.
Product differentiation is limited for commodity buffers and minerals, leading to price competition.
Competition in probiotics is increasingly based on strain performance, field evidence and technical service.
Threat of New Entrants: Medium; Low barriers for basic formulations; registration costs and scale for regulated and active-oxygen products.
Bargaining Power of Suppliers: Medium; Abundant commodity inputs; concentrated peroxide and proprietary strain supply.
Bargaining Power of Buyers: High; Price-sensitive farmers, low switching costs, influential dealers and integrators.
Threat of Substitutes: Medium; Aeration, water exchange, biofloc and RAS biofiltration reduce some chemical needs.
Intensity of Competitive Rivalry: High; Fragmented market with many regional formulators and price competition.
Market estimates by geography (2032)
InsightAsia Pacific leads with $202.32M by 2032, while Middle East & Africa is projected to grow fastest at a 6.3% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $8.42M | $9.88M | $11.82M | 3.5% | 5% |
| Europe | $11.76M | $13.85M | $16.60M | 3.5% | 7% |
| Asia Pacific | $129.36M | $161.87M | $202.32M | 4.6% | 80% |
| Latin America | $9.34M | $12.39M | $16.08M | 5.6% | 6% |
| Middle East & Africa | $3.02M | $4.19M | $5.58M | 6.3% | 2% |
| Total | $161.90M | $202.20M | $252.40M | 4.5% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$252.40M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Oxygen Releasers & Others | $87.01M | 4.3% | 34% |
| pH Adjusters & Buffers | $84.34M | 3.8% | 33% |
| Probiotics | $81.06M | 5.7% | 32% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Aquaculture Water Treatment Chemicals Market covering market dynamics, competitive landscape, and strategic outlook.
The Aquaculture Water Treatment Chemicals Market market is projected to reach $252.40M by 2032, growing at 4.5% CAGR. The Oxygen Releasers & Others segment holds the largest share.
The Global Aquaculture Water Treatment Chemicals Market is shaped by the growth and intensification of aquaculture, by recurring disease and water quality problems in pond and tank systems, and by tightening controls on antibiotic and chemical residues in farmed seafood. These forces support steady demand for pH management, oxygen supply and microbial water treatment, while farm profitability, product quality concerns and environmental scrutiny of chemical treatments moderate the pace of growth. The growth factor analysis below summarises the main macro and micro factors and their expected impact over three periods within the forecast. The impact scores, on a scale of 1 to 10, are analyst assessments based on the secondary and primary research conducted for this study.
Expansion and Intensification of Aquaculture Production
Aquaculture has become the main source of aquatic animal production. According to the FAO's State of World Fisheries and Aquaculture 2024, aquaculture output of aquatic animals reached 94.4 million tonnes in 2022, surpassing capture fisheries for the first time. Growth is concentrated in Asia, which accounts for around nine-tenths of farmed production, led by China, India, Indonesia, Vietnam and Bangladesh. Much of this growth comes from intensification rather than new land: farmers are raising stocking densities, shortening crop cycles and running more cycles per year. Higher biomass per hectare increases feed input, metabolic waste and oxygen demand, which in turn raises the frequency of pH swings, low dissolved oxygen events and ammonia and hydrogen sulphide accumulation. Intensively managed ponds therefore require regular liming and buffering during pond preparation and grow-out, routine application of oxygen-releasing compounds during critical periods, and repeated dosing of probiotics to break down organic sludge. As production expands in both established and emerging producing countries, consumption of these inputs rises in proportion to farmed area and, more significantly, to the intensity of production.
Shift from Antibiotics to Preventive and Biological Water Management
Residue limits in major importing markets and national restrictions on antibiotic use are pushing farmers towards preventive health management. Importing markets such as the European Union, the United States and Japan test farmed seafood for veterinary drug residues, and shipments that fail these tests can be rejected, which carries significant commercial risk for exporting countries. In India, the Coastal Aquaculture Authority prohibits the use of antibiotics and pharmacologically active substances that are harmful to human health in coastal aquaculture and registers antibiotic-free inputs used on farms, while MPEDA runs residue control programmes for export shrimp. In response, farmers increasingly rely on water and soil probiotics, nitrifying bacteria and enzyme–microbe blends to maintain stable microbial communities, suppress Vibrio and other pathogens, and reduce toxic metabolites. This shift is the main reason Probiotics is the fastest-growing product type in this market, and it also supports demand for pH buffers and mineral blends that keep pond conditions within the range where beneficial microbes are effective.
Disease Pressure in Shrimp Farming
Shrimp aquaculture has experienced repeated losses from diseases such as white spot syndrome, acute hepatopancreatic necrosis disease (AHPND, commonly called early mortality syndrome) and hepatopancreatic microsporidiosis caused by Enterocytozoon hepatopenaei (EHP). Outbreaks are strongly associated with poor water and sediment quality, including low dissolved oxygen, high organic load, pH instability and the build-up of Vibrio populations. Since there are few approved therapeutic options for shrimp, farmers rely on biosecurity and water quality management to reduce risk. This includes disinfection of source water and ponds before stocking, liming and mineral correction, oxygen supplementation during periods of plankton crashes or high temperatures, and regular probiotic dosing. Shrimp, which accounts for half of the market in 2025, is therefore the most input-intensive species group, and continued disease pressure in Asia and Latin America sustains demand across all three product types.
Growth of Recirculating and Land-Based Aquaculture
Recirculating aquaculture systems (RAS) and other land-based farms are being developed for salmon, trout, shrimp and other species in North America, Europe, the Middle East and Asia, driven by biosecurity, proximity to markets, water scarcity and restrictions on new open-water sites. In Canada, the federal government has announced the transition away from open-net pen salmon farming in British Columbia coastal waters by mid-2029, which has increased interest in closed and land-based systems. RAS operations depend on continuous control of water chemistry: nitrification in biofilters consumes alkalinity and lowers pH, so operators dose sodium bicarbonate or other buffers routinely; hydrogen peroxide and peracetic acid are used for water hygiene and system disinfection; and oxygen must be supplied continuously. Although RAS currently represents a small share of global production, its consumption of treatment inputs per tonne of fish is high, which supports above-average growth in pH buffers and active-oxygen products in developed markets.
Next-Generation Probiotics and Application-Specific Formulations
There is scope for suppliers to differentiate through multi-strain products tailored to specific species, salinities and production stages, and through convenient formats such as tablets, wafers and stabilised liquids. Recent launches, such as probiotic wafers designed for direct application in ponds and nurseries, illustrate the move towards products that are easier for farmers to dose correctly. Products supported by robust field trials and clear performance claims can command premium pricing.
Emerging Aquaculture Markets in Latin America and the Middle East & Africa
Latin America and the Middle East & Africa are the fastest-growing regions in this market, at CAGRs of 5.39% and 5.96% respectively. Ecuador's shrimp industry, Brazil's tilapia sector and Saudi Arabia's aquaculture development programme under Vision 2030 are expanding farmed production and creating demand for professional water management. Suppliers that establish distribution and technical service in these regions early can build strong positions.
Integrated Water Quality Management and Precision Dosing
The growing use of water quality sensors, automated feeders and farm management software allows farmers to monitor dissolved oxygen, pH and ammonia continuously. This creates opportunities for suppliers to offer integrated programmes that combine diagnostic testing, dosing recommendations and product supply, moving from transactional product sales to service-based relationships with larger farms and integrators.
Farm Profitability and Price Sensitivity
Most aquaculture farms, particularly in Asia and Latin America, are small or medium enterprises with limited working capital. Shrimp farm-gate prices have been under pressure in recent years due to strong supply growth, and changes in trade conditions, including higher US import tariffs on seafood from several exporting countries in 2025, have added uncertainty for exporters. When margins are squeezed, farmers tend to reduce discretionary input spending, switch to cheaper unbranded products, or reduce application rates, which slows value growth in the market.
Product Quality Variability and Limited Efficacy Evidence
A large share of water treatment products, particularly probiotics and mineral blends sold through dealer networks, is produced by small formulators with variable quality control. Viable cell counts in probiotic products can differ from label claims, and independent field efficacy data are often limited. Inconsistent results reduce farmer confidence and slow adoption of premium products, while regulators in several countries are tightening product registration requirements in response.
Environmental and Regulatory Scrutiny of Chemical Treatments
The discharge of treated water and the use of disinfectants and oxidising agents in open systems are subject to environmental regulation. Hydrogen peroxide treatments for sea lice in salmon farming, for example, are regulated as veterinary medicines in Norway and the UK and are subject to discharge controls. Registration costs and regulatory timelines for new active substances can be high relative to the size of the aquaculture segment, which limits product innovation in chemical treatments.
Challenge: Climate Variability and Extreme Weather
Higher water temperatures reduce oxygen solubility and increase the metabolic rate of farmed animals, while heavy rainfall and flooding cause sudden changes in salinity, pH and turbidity. These events increase the need for emergency oxygen supplementation and pH correction, but they also cause crop losses that reduce farmers' ability to pay for inputs, making demand more volatile.
Challenge: Fragmented Distribution and Counterfeit Products
In many producing countries, water treatment products reach farmers through multiple layers of distributors and retail dealers, which adds cost and makes it harder for manufacturers to provide technical support. The presence of counterfeit or substandard products in some markets undermines brand value and farmer trust.
Trend: Substitution of Chemical Inputs by Biological Solutions
Farmers and integrators are increasingly using microbial and enzyme-based products alongside or instead of chemical disinfectants and oxidisers. This trend favours biosolutions companies and fermentation-based producers, and is reflected in the faster growth of Probiotics relative to other product types across all regions in this study.
Trend: Consolidation and Portfolio Restructuring among Suppliers
Major suppliers have restructured their animal health and nutrition businesses since 2022. Novozymes and Chr. Hansen combined to form Novonesis in January 2024; dsm-firmenich agreed in February 2026 to sell its Animal Nutrition & Health business to CVC Capital Partners; and Benchmark Holdings sold its Genetics business in March 2025 and became a private company focused on INVE Aquaculture and its health business. These changes are reshaping the ownership of key aquaculture probiotic and health product portfolios.
The value chain of the Global Aquaculture Water Treatment Chemicals Market runs from raw material suppliers through manufacturers and formulators, distribution channels and end users.
Raw materials and inputs: Limestone, dolomite and quicklime from mining and lime producers; soda ash and sodium bicarbonate from soda ash producers; hydrogen peroxide, calcium peroxide and sodium percarbonate from active-oxygen chemical producers; bacterial strains, fermentation media and enzymes for probiotics; and carriers, binders and packaging materials.
Manufacturing and formulation: Chemical producers manufacture active-oxygen compounds and carbonates at scale, while biosolutions companies produce probiotic strains through fermentation and downstream processing. Formulators blend minerals, buffers, microbes and enzymes into finished products in powder, granule, tablet and liquid form, with quality control for purity, concentration and viable cell counts.
Distribution and channels: Products reach farms through direct sales to large integrators and farm groups, through national and regional distributors, through aqua-input retail dealers in farming clusters, through feed companies that bundle health products with feed, and increasingly through online channels. Technical service teams and dealers often provide pond testing and dosing advice.
End users: Shrimp farms, fish farms (pond, cage and tank), hatcheries and nurseries, recirculating aquaculture system operators, and producers of molluscs and other species.
Value addition is highest at the formulation and branding stage for probiotics and specialty blends, where proprietary strains, field trial data and technical support allow premium pricing. Commodity inputs such as agricultural lime are lower-value and compete primarily on price and local availability.
North America
United States: The Food and Drug Administration's Center for Veterinary Medicine regulates drugs used in aquaculture under the Federal Food, Drug, and Cosmetic Act, including approved products such as 35% PEROX-AID (hydrogen peroxide). FDA also maintains an enforcement policy for low regulatory priority aquaculture drugs, which covers substances such as calcium oxide, sodium bicarbonate, sodium chloride and potassium chloride when used under specified conditions. Disinfectants and pesticidal products are registered by the Environmental Protection Agency under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), and discharges from concentrated aquatic animal production facilities are governed by EPA effluent guidelines (40 CFR Part 451) under the Clean Water Act.
Canada: Veterinary drugs are regulated by Health Canada, pest control products by the Pest Management Regulatory Agency under the Pest Control Products Act, and the deposit of drugs and pesticides from aquaculture facilities by the Aquaculture Activities Regulations under the Fisheries Act.
Europe
European Union: Veterinary medicinal products are regulated by Regulation (EU) 2019/6; biocidal products, including disinfectants used in aquaculture, by the Biocidal Products Regulation (EU) No 528/2012; and probiotics used as feed additives by Regulation (EC) No 1831/2003. Maximum residue limits for veterinary substances in foods of animal origin are set by Commission Regulation (EU) No 37/2010. Water discharges are subject to the Water Framework Directive (2000/60/EC), and organic aquaculture is governed by Regulation (EU) 2018/848.
Norway and the United Kingdom: Fish medicines, including hydrogen peroxide for sea lice control, are authorised by the Norwegian Medical Products Agency and the UK Veterinary Medicines Directorate respectively. Aquaculture operations in Norway are licensed under the Aquaculture Act.
Asia Pacific
India: The Coastal Aquaculture Authority Act, 2005, as amended by the Coastal Aquaculture Authority (Amendment) Act, 2023, governs coastal aquaculture. The Authority registers farms and hatcheries, prohibits the use of antibiotics and pharmacologically active substances that are harmful to human health, and maintains a registration system for antibiotic-free inputs. MPEDA and the Export Inspection Council operate residue monitoring for exported seafood.
China: Veterinary drugs, including those used in aquaculture, are regulated under the Regulations on the Administration of Veterinary Drugs, administered by the Ministry of Agriculture and Rural Affairs.
Vietnam: The Law on Fisheries (2017) and its implementing decrees require registration of products used for aquaculture environmental treatment.
Latin America and Middle East & Africa
Chile: The National Fisheries and Aquaculture Service (SERNAPESCA) supervises aquaculture health programmes and the use of veterinary products in salmon farming, while the Agricultural and Livestock Service (SAG) registers veterinary medicines.
Middle East & Africa: Aquaculture regulation is evolving. In Saudi Arabia, aquaculture development is overseen by the Ministry of Environment, Water and Agriculture, and imports of veterinary and aquaculture inputs are subject to registration with national authorities.
The table below summarises key product launches, mergers and acquisitions, partnerships, regulatory approvals and expansions undertaken by the profiled companies since 2022.
Mar 2022: Syndel; Regulatory approval; Received a UK Marketing Authorisation from the Veterinary Medicines Directorate for the Syncaine (MS-222) fish anaesthetic.
Aug 2022: Syndel; Product launch; Introduced HALAMID AQUA (chloramine-T) for aquaculture disinfection in North America.
Oct 2022: Syndel; Regulatory approval; Obtained approval for use of Virkon Aquatic disinfectant in California.
Apr 2023: Kemin Industries; Product launch; Kemin AquaScience launched Pathorol for farmed shrimp in India, Thailand, Vietnam, Indonesia and Singapore.
May 2023: Evonik Industries; Product launch; Launched EPA-registered VIGOROX Trident peracetic acid in North America for water quality control in recirculating systems and ponds.
May 2023: dsm-firmenich; Merger; Completed the merger of Royal DSM and Firmenich to form dsm-firmenich.
2023: Evonik Industries; Acquisition; Took full ownership of Thai Peroxide Co. in Thailand by acquiring the remaining 50% stake from Aditya Birla, expanding hydrogen peroxide and peracetic acid production in Asia.
Dec 2023: Solvay; Demerger; Completed the spin-off of Syensqo; Solvay retained its peroxides business, including aquaculture products.
Jan 2024: Novonesis; Merger; Completed the combination of Novozymes and Chr. Hansen, creating Novonesis.
Jan 2024: Benchmark Holdings; Strategic review; Launched a formal sale process for the company or its individual businesses.
Feb 2024: dsm-firmenich; Divestment; Announced its intention to separate the Animal Nutrition & Health business from the group.
Mar 2024: Lallemand Animal Nutrition; Partnership; Advanced its collaboration with microXpace on alpha-gal immunity technology against fish and poultry parasites into product development.
Aug 2024: Lallemand Animal Nutrition; Partnership; Launched the LALProMucoBath research project with the University of Plymouth on salmon skin and gill microbiomes.
Mar 2025: Benchmark Holdings; Divestment; Completed the sale of its Genetics business to Novo Holdings for up to GBP 260 million, refocusing on INVE Aquaculture and Health.
Jun 2025: Novonesis; Acquisition; Completed the acquisition of dsm-firmenich's share of the Feed Enzyme Alliance for EUR 1.5 billion.
Jun 2025: Solvay; Expansion; Peróxidos do Brasil, a Solvay joint venture, announced a USD 12 million investment in its hydrogen peroxide plant in Coronel, Chile, serving markets including aquaculture.
Aug 2025: Benchmark Holdings; Delisting; Cancelled trading of its shares on AIM and Euronext Growth Oslo and re-registered as a private company.
Sep 2025: Kemin Industries; Acquisition; Acquired CJ Youtell Biotech, an enzymes and fermentation company in China serving feed and aquaculture markets.
Oct 2025: Biostadt India; Expansion; Leased a site in Ras Al Khaimah Economic Zone, UAE, to build a biostimulant manufacturing plant expected to begin operations in 2026.
Feb 2026: dsm-firmenich; Divestment; Agreed to sell its Animal Nutrition & Health business, including the AquaStar probiotics range, to CVC Capital Partners; completion is expected at the end of 2026.
Mar 2026: Growel Formulations; Investment; Made a strategic investment in Provet Pharma, a poultry healthcare company.
Jun 2026: Benchmark Holdings (INVE Aquaculture); Product launch; Launched Sanolife PRO-TAB for Fish, a probiotic wafer for fish health and nursery performance, at World Aquaculture Singapore 2026.
Jul 2026: Lallemand; Acquisition; Completed the acquisition of BIO-CAT Enzymes & Microbials (United States), adding enzyme and microbial production capacity.
Political
Governments in major producing countries support aquaculture through programmes such as India's Pradhan Mantri Matsya Sampada Yojana (PMMSY) and Saudi Arabia's Vision 2030, which expand farmed area and input demand.
Trade policies, including tariffs on seafood imports, affect the profitability of export-oriented shrimp and fish farms.
Economic
Farm-gate prices of shrimp and fish directly influence how much farmers spend on water treatment inputs.
Raw material and energy costs affect the production cost of lime, carbonates and active-oxygen chemicals.
Rising seafood consumption in Asia, the Middle East and Africa supports long-term production growth.
Social
Consumer concern over antibiotic residues and food safety is encouraging residue-free production practices.
Aquaculture provides livelihoods for millions of small-scale farmers, many of whom have limited technical knowledge of water quality management.
Technological
Advances in strain selection, fermentation and formulation are improving the stability and efficacy of probiotics.
Water quality sensors and farm management software enable precision dosing of buffers, oxygen and probiotics.
RAS and biofloc technologies are changing the mix of inputs required by intensive farms.
Environmental
Climate change is increasing water temperatures, extreme rainfall and oxygen depletion events in ponds.
Effluent regulations and community concerns over coastal pollution are pushing farms to treat and manage discharge water.
Legal
Registration requirements for aquaculture inputs, veterinary medicines and biocides vary by country and increase compliance costs.
Maximum residue limits in importing markets create legal and commercial risks for farms that use prohibited substances.
Profiles of 31 companies operating in the Aquaculture Water Treatment Chemicals Market market, including revenue, employee count, and market positioning where available.
Showing 31 of 31 companies
Evonik is Germany's second-largest listed chemicals group after BASF and one of Europe's broadest pure-play specialty chemicals companies, generating €14.1bn of sales and €1.87bn adjusted EBITDA in FY2025. Since April 2025 it has been organised into two operating segments — Custom Solutions (formulated, application-driven specialties for coatings, personal care, pharma, and industrial additives) and Advanced Technologies (scale- and technology-driven platforms in silica, hydrogen peroxide, high-performance polymers, crosslinkers and animal-nutrition amino acids) — plus an Infrastructure segment (SYNEQT site services, Oxeno C4 chemicals) earmarked for divestment. Its competitive identity rests on deep process know-how, integrated German Verbund sites (Marl, Wesseling, Rheinfelden, Essen, Hanau), and leadership positions in global niches (fumed silica, DL-methionine, PA12, pharma excipients/lipids). The investment case is a transformation story — €400m-plus cost reduction, portfolio pruning, deleveraging — now overlaid by a live takeover approach from BASF and a near-majority foundation shareholder whose stance is pivotal. --- ### Company self-description Evonik describes itself as a global chemical company that goes "beyond chemistry" by combining innovative strength with leading technological expertise, providing customers with a competitive advantage through tailor-made products and solutions — positioning itself as a "superforce for industry" (company boilerplate, press releases 2026; Company Factbook 2026). Its stated strategic pillars (Capital Markets Day, 22 May 2025) are: a differentiated portfolio in two segments, sustainable innovation, a balanced regional footprint (ambition of roughly one-third of sales in each of Americas, EMEA and Asia-Pacific), and a performance culture. ### Independent characterisation Evonik is a mid-cap, diversified specialty and "semi-specialty" chemicals manufacturer. Roughly 80% of FY2025 sales (€11.5bn of €14.1bn) came from the two core segments; the remaining ~18–19% came from Infrastructure & Other, which bundles low-margin site services and the cyclical C4 (Oxeno) petrochemical chain. The business is overwhelmingly a product business (manufactured chemicals sold B2B under supply contracts, frame agreements and spot), with smaller service/contract components: (i) pharma CDMO and contract manufacturing (Health Care — lipids/LNPs, drug substances, oral drug delivery), (ii) site infrastructure and utility services sold by SYNEQT to ~two dozen third-party companies in the Marl and Wesseling chemical parks, and (iii) licensing/technology (e.g., HPPO hydrogen peroxide technology with partners; catalysts). Subscription revenue is negligible. Precise revenue-model split (product vs service vs licensing) is n/d. ### Value-chain position Evonik sits mid-stream: it buys petrochemical feedstocks (C4 raffinate, propylene, methanol, ammonia, natural gas/energy, silicon metal, sulphur) and converts them into intermediates and formulated specialties sold to formulators and OEMs. Upstream integration is partial (own C4 cracking downstream of refinery/cracker streams at Marl and Antwerp; own HCN and methionine chain in Antwerp, Mobile and Singapore). Downstream, it rarely sells to consumers; its products are ingredients typically <5% of the customer's cost but critical to performance ("small cost share, high value-in-use"), which supports pricing power in the specialty businesses. ### Customer types and end markets Customers include paint and coatings formulators, adhesives and sealants makers, tyre and rubber producers (silica/silanes), cosmetic and household-care brands, pharmaceutical and biotech companies (excipients, lipids, CDMO), animal-feed mills and integrators (methionine), plastics and automotive suppliers (PA12, PEEK), aerospace (ROHACELL foams), pulp & paper, electronics and semiconductors (high-purity silanes/chlorosilanes, H2O2), renewable energy and hydrogen (membranes, catalysts), and biodiesel producers (alkoxide catalysts). End-market exposure is broad: consumer/personal care, health care, food/feed, automotive and mobility, construction, coatings, industrial, energy/agriculture. A precise end-market % split for FY2025 is n/d in sources reviewed.
| Metric | FY2023 | FY2024 | FY2025 | FY2026 | |---|---|---|---|---| | Employees (approx., headcount) | 9000 | 9000 | 8700 | 8400 | Note: FY2023–FY2025 are approximations from company communications; the FY2025 figure is an interpolation and should be treated as not publicly verified. FY2026 (~8,400) is stated in every 2026 Solvay press release. The FY2025 media presentation references a workforce trajectory toward ~9,000 "by 2027" in a context that could not be fully parsed. Solvay is a 163-year-old Belgian producer of essential, largely commoditised inorganic and mid-chain chemicals whose franchise rests on scale, cost position and process know-how rather than proprietary molecules. Post-demerger, the group is anchored by two global leaderships — soda ash and its derivatives (including sodium bicarbonate) and hydrogen peroxide — complemented by highly dispersible silica for fuel-efficient tyres, the Brazil-based Coatis phenol/solvents chain, and a Special Chem unit housing rare earths and fluorine. With €4.3 billion of underlying sales and an EBITDA margin that has stayed above 20% through a severe soda ash downcycle, Solvay positions itself as a cash-generating, dividend-paying "essential chemistry" company. Its equity story now pivots on three levers: structural cost reduction (€300 million cumulative by end-2026), decarbonisation of coal-fired soda ash plants, and optionality in Western rare earths separation at La Rochelle — an asset increasingly seen as strategic outside China. --- ### Company's own description Solvay describes itself as "a pioneering chemical company with a legacy rooted in founder Ernest Solvay's pivotal innovations in the soda ash process," delivering essential solutions that address needs such as purifying air and water, preserving food, protecting health, making tyres more sustainable, and cleaning and protecting homes. Its corporate purpose, as presented with FY2025 results, is "essential chemistry, making progress possible for generations," executed through four strategic levers: operational excellence, energy transition, process innovation and production capacity (Source: FY2025 media presentation, 24 Feb 2026). ### Independent characterisation Solvay is today a mid-cap, cyclical, largely B2B commodity and intermediate chemicals producer. Roughly 60% of sales and around two-thirds of segment EBITDA come from Basic Chemicals (soda ash, bicarbonate, peroxides), where pricing is set by global supply-demand balances — notably the seaborne soda ash market, which has been depressed by Chinese and Turkish capacity additions. The remaining ~40% of sales (Performance Chemicals) are more differentiated (silica for tyres, rare earths formulations, autocatalyst materials, fluorine specialties, phenol/solvent chain) but smaller and more volatile in margin. ### Business and revenue model | Dimension | Characterisation | |---|---| | Revenue mix | ~100% product sales; no material service, subscription or licensing revenue disclosed. Minor technology/licensing elements exist (e.g., samarium process technology supplied to Permag, 2025) but are not separately reported | | Contract structure | Soda ash: largely annual contracts in Europe/US, spot/short-term in seaborne Asia; peroxides: long-term on-site/captive supply to HPPO (propylene oxide) plants plus merchant sales; silica: multi-year qualifications with tyre makers | | Value chain position | Upstream/mid-stream: converts salt, limestone, trona, hydrogen, natural gas/energy and mineral concentrates into base inorganic chemicals and intermediates | | Cost drivers | Energy (gas, coal, power), CO2 allowances (EU ETS), freight, raw materials (limestone, salt, trona, ore concentrates), fixed costs | | Customer types | Glass manufacturers (flat, container, solar), detergent producers, chemical companies, tyre makers, pulp & paper, electronics/semiconductor fabs, food/feed/pharma, flue gas treatment operators, mining, automotive catalysts, magnet makers | | End-markets | Construction and automotive glass, solar glass, consumer goods (detergents), food & pharma (bicarbonate), environment (flue gas treatment, water), semiconductors (electronic-grade H2O2), mobility (tyres, catalysts, EV magnets), agro and coatings (solvents) | ### Segment business descriptions (as defined by Solvay) **Basic Chemicals:** Soda Ash & Derivatives and Peroxides businesses. **Performance Chemicals:** Coatis, Silica and Special Chem businesses (Source: Q1/Q2/FY2025 media presentations). **Corporate & Business Services:** corporate functions, energy services and other.
3 interactive charts drawn from the Aquaculture Water Treatment Chemicals Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Aquaculture Water Treatment Chemicals Market By Species
Global Aquaculture Water Treatment Chemicals Market By Product Type
Global Aquaculture Water Treatment Chemicals Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
